| Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease M Ioannou, T Alissafi, I Lazaridis, G Deraos, J Matsoukas, A Gravanis, ... The Journal of Immunology 188 (3), 1136-1146, 2012 | 270 | 2012 |
| Round and round we go: cyclic peptides in disease M Katsara, T Tselios, S Deraos, G Deraos, MT Matsoukas, E Lazoura, ... Current medicinal chemistry 13 (19), 2221-2232, 2006 | 195 | 2006 |
| Design of Novel Cyclic Altered Peptide Ligands of Myelin Basic Protein MBP83−99 That Modulate Immune Responses in SJL/J Mice M Katsara, G Deraos, T Tselios, J Matsoukas, V Apostolopoulos Journal of medicinal chemistry 51 (13), 3971-3978, 2008 | 62 | 2008 |
| Recognition pliability is coupled to structural heterogeneity: a calmodulin intrinsically disordered binding region complex M Nagulapalli, G Parigi, J Yuan, J Gsponer, G Deraos, VV Bamm, ... Structure 20 (3), 522-533, 2012 | 59 | 2012 |
| Citrullination of Linear and Cyclic Altered Peptide Ligands from Myelin Basic Protein (MBP87−99) Epitope Elicits a Th1 Polarized Response by T Cells Isolated … G Deraos, K Chatzantoni, MT Matsoukas, T Tselios, S Deraos, M Katsara, ... Journal of medicinal chemistry 51 (24), 7834-7842, 2008 | 58 | 2008 |
| Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding K Gkountelias, T Tselios, M Venihaki, G Deraos, I Lazaridis, O Rassouli, ... Molecular pharmacology 75 (4), 793-800, 2009 | 55 | 2009 |
| Altered peptide ligands of myelin basic protein (MBP87–99) conjugated to reduced mannan modulate immune responses in mice M Katsara, E Yuriev, PA Ramsland, T Tselios, G Deraos, A Lourbopoulos, ... Immunology 128 (4), 521-533, 2009 | 54 | 2009 |
| Design and Synthesis of a Cyclic Double Mutant Peptide (cyclo(87−99)[A91,A96]MBP87−99) Induces Altered Responses in Mice after Conjugation to Mannan … M Katsara, G Deraos, T Tselios, MT Matsoukas, I Friligou, J Matsoukas, ... Journal of medicinal chemistry 52 (1), 214-218, 2009 | 45 | 2009 |
| Towards immunotherapeutic drugs and vaccines against multiple sclerosis M Katsara, J Matsoukas, G Deraos, V Apostolopoulos Acta biochimica et biophysica Sinica 40 (7), 636-642, 2008 | 44 | 2008 |
| A double mutation of MBP83–99 peptide induces IL-4 responses and antagonizes IFN-γ responses M Katsara, E Yuriev, PA Ramsland, G Deraos, T Tselios, J Matsoukas, ... Journal of neuroimmunology 200 (1-2), 77-89, 2008 | 43 | 2008 |
| Mannosylation of mutated MBP83–99 peptides diverts immune responses from Th1 to Th2 M Katsara, E Yuriev, PA Ramsland, G Deraos, T Tselios, J Matsoukas, ... Molecular immunology 45 (13), 3661-3670, 2008 | 41 | 2008 |
| Regulatory cell populations in relapsing-remitting multiple sclerosis (RRMS) patients: effect of disease activity and treatment regimens M Rodi, N Dimisianos, AL De Lastic, P Sakellaraki, G Deraos, ... International Journal of Molecular Sciences 17 (9), 1398, 2016 | 32 | 2016 |
| Properties of myelin altered peptide ligand cyclo (87-99)(Ala91, Ala96) MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis G Deraos, M Rodi, H Kalbacher, K Chatzantoni, F Karagiannis, ... European journal of medicinal chemistry 101, 13-23, 2015 | 24 | 2015 |
| Comparison of proposed putative active conformations of myelin basic protein epitope 87− 99 linear altered peptide ligands by spectroscopic and modelling studies: the role of … ED Mantzourani, TV Tselios, SG Grdadolnik, JA Platts, A Brancale, ... Journal of medicinal chemistry 49 (23), 6683-6691, 2006 | 23 | 2006 |
| Cyclic MOG35–55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis A Lourbopoulos, G Deraos, MT Matsoukas, O Touloumi, ... Bioorganic & medicinal chemistry 25 (15), 4163-4174, 2017 | 18 | 2017 |
| Cyclic citrullinated mbp87–99 peptide stimulates t cell responses: Implications in triggering disease V Apostolopoulos, G Deraos, MT Matsoukas, S Day, L Stojanovska, ... Bioorganic & medicinal chemistry 25 (2), 528-538, 2017 | 12 | 2017 |
| Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis A Lourbopoulos, MT Matsoukas, M Katsara, G Deraos, A Giannakopoulou, ... Bioorganic & Medicinal Chemistry 26 (9), 2221-2228, 2018 | 10 | 2018 |
| Comparison of proposed putative active conformations of linear altered peptide ligands of myelin basic protein epitope 87–99 by spectroscopic and modelling studies: the role of … ED Mantzourani, TV Tselios, SG Grdadolnik, JA Platts, A Brancale, ... J. Med. Chem 49 (23), 6683-6691, 2006 | 10 | 2006 |
| Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82–98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II G Deraos, E Kritsi, MT Matsoukas, K Christopoulou, H Kalbacher, ... Brain Sciences 8 (12), 213, 2018 | 9 | 2018 |
| Development and characterization of a novel conjugated methamphetamine vaccine MK Hossain, M Davidson, J Feehan, G Deraos, K Nurgali, J Matsoukas, ... Vaccine 40 (41), 5882-5891, 2022 | 7 | 2022 |
Vasso ApostolopoulosProfessor of Immunology, Victoria University, Australia在 vu.edu.au 的电子邮件经过验证
